BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 6809029)

  • 1. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
    Gomes MA; Dambuyant C; Thivolet J; Bussy R
    Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predominance of IgG4 in prodromal bullous pemphigoid.
    Lamb PM; Patton T; Deng JS
    Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complement fixing ability of anti-basement membrane zone IgG subclass of herpes gestationis and bullous pemphigoid.
    Suzuki M; Watanabe C; Yaoita H
    Acta Derm Venereol; 1989; 69(1):6-11. PubMed ID: 2563610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR
    J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
    Brooks WS; Lee YY; Abell E; Deng JS
    J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
    Gammon WR; Inman AO; Wheeler CE
    J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
    Allen J; Shears E; Powell J; Wojnarowska F
    Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid.
    Kelly SE; Wojnarowska F
    Br J Dermatol; 1988 Jan; 118(1):31-40. PubMed ID: 3277659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune complexes in pemphigus and bullous pemphigoid.
    Ahmed AR; Moy RL; Chia D; Barnett EV
    Dermatologica; 1983; 166(4):175-80. PubMed ID: 6343146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
    Jordon RE; Struve MF; Bushkell LL
    Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous pemphigoid and antinuclear antibodies. Unmasking of basement membrane fluorescence in sodium chloride-treated substrates.
    Danno K; Okamoto H; Miyauchi H; Imamura S
    Arch Dermatol; 1982 Jan; 118(1):37-9. PubMed ID: 7036909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of sodium-chloride separated human skin in detection of circulating anti-basement membrane zone antibodies.
    Rasmussen HB; Brandrup F; Andersen J; Hagdrup H
    Acta Derm Venereol; 1989; 69(6):515-9. PubMed ID: 2575326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low pH condition impairs BP-IgG binding to the basement membrane zone.
    Im D; Ueda K; Niwa H; Tanaka K; Iwata H
    J Dermatol; 2024 May; 51(5):643-648. PubMed ID: 38482975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.
    Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ
    Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA basement membrane zone autoantibodies in bullous pemphigoid detect epidermal antigens of 270-280 kDa, 230 kDa, and 180 kDa molecular weight by immunoblotting.
    Kirtschig G; Wojnarowska F
    Clin Exp Dermatol; 1999 Jul; 24(4):302-7. PubMed ID: 10457136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized bullous pemphigoid with negative immunofluorescence.
    Silber JG; Brody N
    Cutis; 1981 Nov; 28(5):562, 565. PubMed ID: 7030649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation.
    Yamada H; Hashimoto T; Nishikawa T
    J Invest Dermatol; 1989 Apr; 92(4):585-7. PubMed ID: 2649595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of linear IgA disease presenting initially with IgG immune deposits.
    Petersen MJ; Gammon WR; Briggaman RA
    J Am Acad Dermatol; 1986 Jun; 14(6):1014-9. PubMed ID: 3522666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.